Taiwan FDA considers use of 2’-FL fermented from new GM source for infant medical foods 04-Oct-2022 By Tingmin Koe Taiwan Food and Drug Administration (FDA) is considering the use of 2’-fucosyllactose (2’-FL) fermented from two new microbial strains in all infant and toddler food products, including Foods for Special Medical Purposes (FSMPs).